30 results
S-3ASR
EX-1.2
APGE
Apogee Therapeutics, Inc.
12 Aug 24
Automatic shelf registration
5:25pm
that are accurate in all material respects and maintain a system of internal accounting controls designed to provide reasonable assurance that: (i … to Section 3(b)(i).
(vii) No Guarantee of Placement, Etc. The Company acknowledges and agrees that (A) there can be no assurance that the Agent
S-3ASR
APGE
Apogee Therapeutics, Inc.
12 Aug 24
Automatic shelf registration
5:25pm
with a specific offering. We take no responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you … no responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you. We and the Sales Agent
DEF 14A
APGE
Apogee Therapeutics, Inc.
24 Apr 24
Definitive proxy
4:15pm
initial public offering.
Consists of fees for assurance and related services associated with consultations on matters directly related to the audit
424B4
4x9yr2enluagu53 sd
11 Mar 24
Prospectus supplement with pricing info
6:01am
10-K
ewceklfn6t48xrgf2isf
5 Mar 24
Annual report
6:15am
DRS
00qs 7hmeci
9 Feb 24
Draft registration statement
12:00am
10-Q
EX-3.2
wwnq3 rra
28 Aug 23
Quarterly report
8:00am
10-Q
nqfnij k9o5
28 Aug 23
Quarterly report
8:00am
424B4
dppr5o7r5kgpq
17 Jul 23
Prospectus supplement with pricing info
4:08pm
S-1
EX-10.9
be6ovce 1bt2b19u
22 Jun 23
IPO registration
4:19pm
S-1
ghlwhsiadv5j 4s7qog
22 Jun 23
IPO registration
4:19pm